1Maron BJ, Olivotto I, Spirito P (2000) Epidemiology of hypertrophic cardiomyopathy related death: revisited in a large non-referral-based patient population. Circulation 102:858-864.

2Cavalcante JL, Barboza JS, Lever HM (2012) Diversity of mitral valve abnormalities in obstructive hypertrophic cardiomyopathy. Prog Cardiovasc Dis 54:517-522.

3Shone JD, Sellers RD, Anderson RC, et al. (1963) The developmental complex of “parachute mitral valve,” supravalvular ring of left atrium, subaortic stenosis, and coarctation of aorta. Am J Cardiol 11:714-725.

4Bolling SF, Iannettoni MD, Dick M 2nd, et al. (1990) Shone’s anomaly: operative results and late outcome. Ann Thorac Surg 49:887-893.

5Nishimura RA, Holmes DR (2004) Hypertrophic obstructive cardiomyopathy. N Engl J Med 350:1320-1327.

6Yavuzgil O, Tülüce K, Şimşek E, et al. (2012) Septal alcohol ablation in hypertrophic obstructive cardiomyopathy: A retrospective review. Turk Gogus Heart Checkers 20:427-433.

7Ünal EU, Özen A, İşcan HZ, et al. (2012). Turk GogusKalpDama, 20: 421-426

8Mataracı İ, Polat A, Songur ÇM, et al. (2009) Hypertrophic obstructive cardiomyopathy. Turk GogusKalpDama 17: 243-248.